Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • koiologist
    Junior Member
    • Dec 2017
    • 2

    #1

    Index Read not mapped

    Hello,

    We are recently experiencing demultiplexing issues on HiSeq 4000, NextSeq 500 and MiSeq, where we have good cluster formations, high read PFs, and greater than 90% >Q30 scores but only a very small fraction <1% of the sequenced indexes passed PF and were mapped. Majority of our read output (>60%) were in the undetermined fastq file but each sample in our pooled library do get a fastq file containing very little reads. We spiked in about 5% PhiX as it is a low diversity library (predetermined viral peptide sequences).

    We are using custom 7-nucleotide IS7 indexes which can be mapped (98%) if only one sample (one index) was ran. Library was gel and pcr purified and bioanalyzer showed a single sharp peak at the expected fragment size.

    Any thoughts?
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    Over-clustered FC's may have good data for main reads but will fail on the index reads (do you have a large number of N's or are the sequences something you do not expect to get in the index).

    You should deliberately under load by 15-20% and/or increase the % of phiX to 10-20% and see if that helps.

    Comment

    • koiologist
      Junior Member
      • Dec 2017
      • 2

      #3
      Thanks for the reply. We had one run on the MiSeq where only a single indexed sample (input library) was sequenced. The run was very over clustered and with very low main read PFs (less than half of read output) but most of the indexes (98%) were mapped. I think in one of our NEXTSeq run we did see a bunch of N's in our index sequences. I do not know if the same things (the N's) are also seen in our MiSeq and HiSeq runs.

      Thanks.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      40 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Working...